First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps. The company produces and sells Omnipod, an automated insulin ...

Patients visiting clinics across multiple hospitals are facing severe difficulties due to an insufficient supply of insulin, chairman of the Doctors’ Trade Union Alliance for Medical and Civil Rights, ...

Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections, ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.